Publications by authors named "Logashvari Naidoo"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

303,543

Total Likes

7,566

Extended Reach

4,028,297

Social Features

267
C
Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial.
Cissy Kityo, Ivan K Mambule, Joseph Musaazi, Simiso Sokhela, Henry Mugerwa, Logashvari Naidoo

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of HPV on risk of HIV acquisition in african women: Analyses from MTN-020/ASPIRE.
Christine L Hathaway, Elizabeth R Brown, Stephen Cherne, Alyssa L Sepulveda, Zvavahera M Chirenje, Logashvari Naidoo

J Natl Cancer Inst· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences for HIV pre-exposure prophylaxis formulations and delivery among young African women: results of a discrete choice experiment.
Wendy W Dlamini, Brenda G Mirembe, Meighan L Krows, Sue Peacock, Philip L Kotze, Logashvari Naidoo

J Int AIDS Soc· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.
Nigel Garrett, Tarylee Reddy, Nonhlanhla Yende-Zuma, Azwidhwi Takalani, Kubashni Woeber, Logashvari Naidoo

PLOS Glob Public Health· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High recent PrEP adherence with point-of-care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort.
Brenda Gati Mirembe, Deborah Donnell, Meighan Krows, Zinhle Zwane, Elizabeth Bukusi, Logashvari Naidoo

J Int AIDS Soc· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial.
Cissy Kityo, Ivan K Mambule, Joseph Musaazi, Simiso Sokhela, Henry Mugerwa, Logashvari Naidoo

Lancet Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs), given to HIV-1 exposed, uninfected neonates and infants: study protocol for a phase I trial.
Ameena Goga, Trisha Ramraj, Logashvari Naidoo, Brodie Daniels, Masefetsane Matlou, Tamon Cafun-Naidoo

BMC Infect Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Logashvari Naidoo

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex.
Erica N Browne, Kristine Torjesen, Brenda Gati Mirembe, Thesla Palanee-Phillips, Nitesha Jeenarain, Logashvari Naidoo

AIDS Care· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Logashvari Naidoo

Nat Commun· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial.
Erica N Browne, Elizabeth R Brown, Thesla Palanee-Phillips, Krishnaveni Reddy, Logashvari Naidoo

J Acquir Immune Defic Syndr· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition: Results From the Phase 2b Antibody-Mediated Prevention Randomized Trials.
Simbarashe Takuva, Shelly T Karuna, Michal Juraska, Erika Rudnicki, Srilatha Edupuganti, Logashvari Naidoo

J Acquir Immune Defic Syndr· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalent human papillomavirus infection increases the risk of HIV acquisition in African women: advancing the argument for human papillomavirus immunization.
Gui Liu, Nelly R Mugo, Elizabeth R Brown, Nyaradzo M Mgodi, Zvavahera M Chirenje, Logashvari Naidoo

AIDS· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence.
Marie C D Stoner, Elizabeth R Brown, Thesla Palanee-Phillips, Leila E Mansoor, Tchangani Tembo, Logashvari Naidoo

AIDS Behav· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated Risk of Bacterial Vaginosis Among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study.
Kathryn Peebles, Flavia M Kiweewa, Thesla Palanee-Phillips, Catherine Chappell, Devika Singh, Logashvari Naidoo

Clin Infect Dis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials.
Yunda Huang, Logashvari Naidoo, Lily Zhang, Lindsay N Carpp, Erika Rudnicki

EBioMedicine· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study.
Jared M Baeten, Thesla Palanee-Phillips, Nyaradzo M Mgodi, Ashley J Mayo, Daniel W Szydlo, Logashvari Naidoo

Lancet HIV· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities.
Krishnaveni Reddy, Cliff Kelly, Elizabeth R Brown, Nitesha Jeenarain, Logashvari Naidoo

AIDS· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social harms in female-initiated HIV prevention method research: state of the evidence.
Elizabeth T Montgomery, Sarah T Roberts, Annalene Nel, Mariette Malherbe, Kristine Torjesen, Logashvari Naidoo

AIDS· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III Trial.
Thesla Palanee-Phillips, Sarah T Roberts, Krishnaveni Reddy, Vaneshree Govender, Logashvari Naidoo

J Acquir Immune Defic Syndr· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of a Validated Risk Score to Predict HIV-1 Acquisition Among African Women Participating in a Trial of the Dapivirine Vaginal Ring.
Jennifer E Balkus, Elizabeth R Brown, Thesla Palanee-Phillips, Flavia Matovu Kiweewa, Nyaradzo Mgodi, Logashvari Naidoo

J Acquir Immune Defic Syndr· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception.
Jennifer E Balkus, Thesla Palanee-Phillips, Krishnaveni Reddy, Samantha Siva, Ishana Harkoo, Logashvari Naidoo

J Acquir Immune Defic Syndr· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.
Jared M Baeten, Thesla Palanee-Phillips, Elizabeth R Brown, Katie Schwartz, Lydia E Soto-Torres, Logashvari Naidoo

N Engl J Med· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis